All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 18 of 206 pages ‹ First < 16 17 18 19 20 > Last ›
HSL17606
 Huckman M
 The Funny Business Of Selling Drugs
 CNBC Blog: Pharma's Market 2010 Apr 12
 
http://www.cnbc.com/id/36425501/The_Funny_Business_Of_Selling_Drugs
HSL17607
 Three major pharmaceutical companies found in breach of ABPI code of practice
 PJ Online 2010 Apr 12
 
http://www.pjonline.com/news/three_major_pharmaceutical_companies_found_in_breach_of_abpi_code_of_practice
HSL17608
 Goozner M
 Bad Medicine: The Real Cost of a Dangerous Drug
 The Fiscal Times 2010 Apr 12
 
http://www.thefiscaltimes.com/Issues/Health-Care/2010/04/12/bad-medicine-the-real-cost-of-a-dangerous-drug.aspx
HSL17609
 Bakalar N
 Study Sees a Slant in Articles on Drug
 The New York Times 2010 Apr 12
 
http://www.nytimes.com/2010/04/13/health/13diab.html
HSL17610
 Richwine L
 US groups urge drug safety steps with industry fees
 Reuters 2010 Apr 12
 
http://www.reuters.com/article/idUSN0913305520100412
HSL17642
 Shankar R
 MCI intensifies demand for amending D&C Act to make pharma companies punishable for bribing doctors
 PharmaBiz.com 2010 Apr 12
 
http://www.essentialdrugs.org/edrug/archive/201004/msg00019.php
HSL17644
 Smith P
 Homeopath defies retraction order
 Pharmacy News 2010 Apr 12
 
http://www.pharmacynews.com.au/article/homeopath-defies-retraction-order/515209.aspx
HSL17754
 Wang N, Lipworth WL, Ritchie JE, Williams KM, Day RO.
 Eliciting views of Australian pharmaceutical industry employees on collaboration and the concept of Quality Use of Medicines.
 Intern Med J 2010 Apr 12;
 
http://www3.interscience.wiley.com/journal/123349392/abstract
HSL17579
 Strengthening the credibility of clinical research
 The Lancet 2010 Apr 10;375:(9722):1225
 
http://www.thelancet.com/journals/lancet/article/PIIS0140673610605235/fulltext
HSL17587
 England's libel laws: silencing scientific debate
 The Lancet 2010 Apr 10;375:(9722):1226
 
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)60525-9/fulltext
HSL17588
 Scull A
 A psychiatric revolution
 The Lancet 2010 Apr 10;375:(9722):1246 - 1247
 
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)60532-6/fulltext
HSL17575
 Schofield H
 Legal fight over Plumpy'nut, the hunger wonder-product
 BBC News 2010 Apr 8
 
http://news.bbc.co.uk/2/hi/europe/8610427.stm
HSL17580
 Fauber J
 69 Wisconsin doctors show up on Pfizer payroll
 The Journal Sentinel 2010 Apr 8
 
http://www.jsonline.com/features/health/90323677.html
HSL17581
 Séguin R
 Quebec pursues drug companies over prices
 The Globe and Mail 2010 Apr 8
 
http://www.theglobeandmail.com/news/national/quebec-pursues-drug-companies-over-prices/article1528438/
HSL17582
 Mack J
 An Analysis of DDMAC Warning Letters Regarding Risk Information in Broadcast Drug Ads
 Pharma Marketing Blog 2010 Apr 8
 
http://pharmamkting.blogspot.com/2010/04/analysis-of-ddmac-warning-letters.html
HSL17595
 Godlee F
 Vested interests
 BMJ 2010 Apr 8;340:
 
http://www.bmj.com/cgi/content/extract/340/apr08_2/c1922
HSL17596
 Arnold M
 Third-parties may be key to social media cred, says survey
 Medical Marketing & Media 2010 Apr 8
 
http://www.mmm-online.com/third-parties-may-be-key-to-social-media-cred-says-survey/article/167621/
HSL17645
 Cannane S
 Homeopathy websites ignore retraction orders
 Lateline : ABC 2010 Apr 8
 
http://www.abc.net.au/lateline/content/2010/s2867990.htm
HSL17554
 Taylor L
 QALYs are 'an industry trick,' says German health chief
 Pharma Times 2010 Apr 7
 
http://www.pharmatimes.com/WorldNews/article.aspx?id=17664
HSL17563
 Moynihan R
 Rosiglitazone, marketing, and medical science
 BMJ 2010 Apr 7;340:
 
http://www.bmj.com/cgi/content/extract/340/apr07_2/c1848
HSL17564
 Moynihan R
 American Council on Science and Health
 BMJ 2010 Apr 7;340:
 
http://www.bmj.com/cgi/content/extract/340/apr07_2/c1819
HSL17565
 Delamothe T
 Data sharing: let the sunshine in
 BMJ 2010 Apr 7;340:
 
http://www.bmj.com/cgi/content/extract/340/apr07_2/c1896
HSL17566
 Grayling AC
 We should reform libel laws in light of Singh victory
 BMJ 2010 Apr 7;340:
 
http://www.bmj.com/cgi/content/extract/340/apr07_2/c1910
HSL17568
 Comer B
 FDA says competing biologic ads both misled
 Medical Marketing & Media 2010 Apr 7
 
http://www.mmm-online.com/fda-says-competing-biologic-ads-both-misled/article/167545/
HSL17576
 Kopf Hirsh J
 Overactive bladder? You might think so after seeing Toviaz ad
 Consumer Reports: Health Blog 2010 Apr 7
 
http://blogs.consumerreports.org/health/2010/04/adwatch-overactive-bladder-you-might-think-so-after-seeing-toviaz-ad-treating-overactive-bladder.html
HSL17597
 Perrone M
 FDA cracking down on fat-melting injections
 The Washington Post 2010 Apr 7
 
http://www.washingtonpost.com/wp-dyn/content/article/2010/04/07/AR2010040702497.html
HSL17598
 Heavey S
 UPDATE 2-U.S. FDA warns Gilead, Biogen over drug promotions
 Reuters 2010 Apr 7
 
http://www.reuters.com/article/idUSN0711570520100407
HSL17601
 George J
 As FDA debates social media rules, pharma isn’t waiting
 Philadelphia Business Journal 2010 Apr 7
 
http://philadelphia.bizjournals.com/philadelphia/stories/2010/04/05/focus1.html
HSL17638
 Drug Marketing Moves to Digital: How Pharmaceutical Companies Pitch Consumers Online
 Center for Digital Democracy 2010 Apr 7
 
http://www.democraticmedia.org/drup-marketing-moves-to-digital
HSL17641
 Sayre A
 La. gets $20 million in Eli Lilly drug settlement
 Yahoo Finance 2010 Apr 7
 
http://www.ibj.com/louisiana-gets-20m-in-lilly-drug-settlement/PARAMS/article/19159
HSL17551
 Curran J
 Drug company expenditures down in Vermont
 Business Week 2010 Apr 6
 
http://www.businessweek.com/ap/financialnews/D9ETIH0O1.htm
HSL17567
 Leonhardt D
 In Medicine, the Power of No
 The New York Times 2010 Apr 6
 
http://www.nytimes.com/2010/04/07/business/economy/07leonhardt.html
HSL17570
 Unnikrishnan CH
 Pfizer, Novartis and Eli Lilly got bulk of contentious patents
 Livemint.com 2010 Apr 6
 
http://www.livemint.com/2010/04/06214301/Pfizer-Novartis-and-Eli-Lilly.html
HSL17552
 Silverman E
 Allan Coukell On Payments To Doctors & Disclosure
 Pharmalot 2010 Apr 5
 
http://www.pharmalot.com/2010/04/allan-coukell-on-payments-to-doctors-disclosure/
HSL17553
 Silverman E
 Who Really Suffers If Pfizer Is Too Big To Fail?
 Pharmalot 2010 Apr 5
 
http://www.pharmalot.com/2010/04/who-really-suffers-if-pfizer-is-too-big-to-fail/
HSL17599
 Drug controller seeks details from Dr Reddy's
 The Hindu Business Line 2010 Apr 5
 
http://www.thehindubusinessline.com/todays-paper/tp-corporate/article988361.ece
HSL17600
 Thomaselli R
 Drug Report: Consumers Rate Rx Remedies Online
 The Advertising Age 2010 Apr 5
 
http://adage.com/digital/article?article_id=143128
HSL17668
 Barkley D
 Schooling doctors
 PM Live 2010 Apr 5
 
http://www.pmlive.com/find_an_article/allarticles/categories/pr_and_med_ed/2010/april/features/schooling_doctors
HSL17584
 Brody H
 CNN: Pfizer Too Big to Prosecute; Shadow Company Takes the Hit
 Hooked: Ethics, Medicine and Pharma 2010 Apr 4
 
http://brodyhooked.blogspot.com/2010/04/cnn-pfizer-too-big-to-prosecute-shadow.html
HSL17555
 Guilliatt R
 Scientist `deceived' by drugs giant
 The Australian 2010 Apr 3
 
http://www.theaustralian.com.au/news/health-science/scientist-deceived-by-drugs-giant/story-e6frg8y6-1225849066072
HSL17556
 Silverman E
 Is The FDA Proposal For DTC Ads Too Vague?
 Pharmalot 2010 Apr 2
 
http://www.pharmalot.com/2010/04/is-the-fda-proposal-for-dtc-ads-too-vague/
HSL17562
 Griffin D, Segal A
 Feds found Pfizer too big to nail
 CNN 2010 Apr 2
 
http://edition.cnn.com/2010/HEALTH/04/02/pfizer.bextra/index.html
HSL17569
 Iskowitz M
 FDA proposes standard for print, broadcast drug ads
 Medical Marketing & Media 2010 Apr 2
 
http://www.mmm-online.com/fda-proposes-standard-for-print-broadcast-drug-ads/article/167222/
HSL17571
 Edwards J
 Memo to the DOJ: 'Pfizer Isn't Too Big to Nail' -- Don't Let Management Off the Hook
 BNet 2010 Apr 2
 
http://industry.bnet.com/pharma/10007526/how-prosecutors-who-say-pfizer-is-too-big-to-nail-are-letting-management-off-the-hook/
HSL17577
 Kinnard M
 APNewsBreak: SC to get $12.7 million under deal with Pfizer Inc. over disputed sales tactics
 The Star Tribune 2010 Apr 2
 
http://www.boston.com/business/healthcare/articles/2010/04/02/apnewsbreak_sc_reaches_127m_deal_with_pfizer/
HSL17583
 Carlat D
 Trickle Down Deception: Restaurants and the Pharmaceutical Industry
 The Carlat Psychiatry Blog 2010 Apr 2
 
http://carlatpsychiatry.blogspot.com/2010/04/trickle-down-deception-restaurants-and.html
HSL17557
 Taylor L
 Drugmakers slam German price moves
 Pharma Times 2010 Apr 1
 
http://www.pharmatimes.com/WorldNews/article.aspx?id=17645
HSL17558
 Dorschner J
 University of Miami database to reveal payments to doctors
 The Miami Herald 2010 Apr 1
 
http://www.miamiherald.com/2010/04/01/1557671/university-of-miami-database-to.html
HSL17572
 Edwards J
 The Big Pharma Transparency Report Card: Congratulations, Merck. Lilly? Needs Improvement
 BNet 2010 Apr 1
 
http://industry.bnet.com/pharma/10007516/the-big-pharma-transparency-report-card-congratulations-merck-lilly-could-do-better/
HSL17612
 Mazur S
 The Peer Review 'Fig Leaf': Vera Hassner Sharav
 Scoop Independent News 2010 Apr 1
 
http://www.scoop.co.nz/stories/HL1004/S00011.htm
HSL17496
 Ryan C, Walter G, Robertson M.
 College activities and the ethics of advertising.
 Australas Psychiatry 2010 Apr;18:(2):101-5
 
http://informahealthcare.com/doi/abs/10.3109/10398561003665577
HSL17497
 Jurd S.
 The marketing of pharmaceutical agents: friend or foe?
 Australas Psychiatry 2010 Apr;18:(2):97-100
 
http://informahealthcare.com/doi/abs/10.3109/10398561003665460
HSL17522
 Cassels A
 Big Pharma’s solution for our health woes: more and more pills for the elderly
 Common Ground 2010 Apr
 
http://www.commonground.ca/iss/225/cg225_cassels.shtml
HSL17535
 Boumil SJ 3rd, Nariani A, Boumil MM, Berman HA.
 Whistleblowing in the pharmaceutical industry in the United States, England, Canada, and Australia.
 J Public Health Policy 2010 Apr;31:(1):17-29
 
http://www.palgrave-journals.com/jphp/journal/v31/n1/abs/jphp200951a.html
HSL17536
 Fullerton CA, Busch AB, Frank RG.
 The rise and fall of gabapentin for bipolar disorder: a case study on off-label pharmaceutical diffusion.
 Med Care 2010 Apr;48:(4):372-9
 
http://pt.wkhealth.com/pt/re/lwwgateway/landingpage.htm;jsessionid=L8wNm6JD8f9P2GBlStd06rl5lwJVn4wSqVV3vdN2snGG7X1jD1c3!-911972257!181195629!8091!-1?issn=0025-7079&volume=48&issue=4&spage=372
HSL17750
 Menghaney L.
 Patent dispute: Delhi High Court gives a boost to access to affordable medicines.
 Indian J Med Ethics 2010 Apr-Jun;7:(2):97-100
 
http://www.ncbi.nlm.nih.gov/pubmed/20432882
HSL17794
 Carmody D, Mansfield PR
 What do medical students think about pharmaceutical promotion?
 Australian Medical Student Journal 2010 Apr;1:(1):54-7
 
http://www.amsj.org/archives/300
HSL17952
 Madden JM, Meza E, Ewen M, Laing RO, Stephens P, Ross-Degnan D.
 Measuring medicine prices in Peru: validation of key aspects of WHO/HAI survey methodology.
 Rev Panam Salud Publica 2010 Apr;27:(4):291-9
 
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892010000400008&lng=en&nrm=iso&tlng=en
HSL18281
 [No authors listed].
 A look back at 2009: one step forward, two steps back.
 Prescrire Int 2010 Apr;19:(106):89-94
 
http://www.ncbi.nlm.nih.gov/pubmed/20568499
HSL18513
 Whayne TF Jr.
 [Problems with statins and the marketing of these medications].
 Rev Med Chil 2010 Apr;138:(4):511-4
 
http://scielo.php/?script=sci_arttext&pid=S0034-98872010000400018&tlng=en&lng=en&nrm=iso
HSL17573
 Edwards J
 J&J Writes a New Chapter of the Pharma Book, 'Why Drug Prices Are High'
 BNet 2010 Mar 31
 
http://industry.bnet.com/pharma/10007503/jj-writes-new-chapter-of-book-titled-why-prices-are-high/
HSL17574
 Edwards J
 Fines Haven't Stopped Drug Company Lawbreaking -- Maybe Jail Time for Executives Would
 BNet 2010 Mar 31
 
http://industry.bnet.com/pharma/10007330/fines-havent-stopped-drug-company-lawbreaking-jailtime-for-executives-might/
HSL17614
 Berkrot B, Pierson R, Krauskopf L
 Pfizer paid $35 mln to doctors over 6 months
 Reuters 2010 Mar 31
 
http://www.reuters.com/article/idUSTRE62U4UM20100331
HSL17615
 Taylor L
 EU govts warned over 'enforced, unpredicted' Rx price cuts
 Pharma Times 2010 Mar 31
 
http://www.pharmatimes.com/WorldNews/article.aspx?id=17639
HSL17616
 Spence D
 Politics of conflict: doctors, like MPs, should declare their interests
 BMJ 2010 Mar 31;340:
 
http://www.bmj.com/cgi/content/extract/340/mar31_2/c1780
HSL17603
 Garattini S, Bertele V
 Europe’s opportunity to open up drug regulation
 BMJ 2010 Mar 30;340:
 
http://www.bmj.com/cgi/content/extract/340/mar30_2/c1578
HSL17544
 Tolve A
 Why Pharma needs a New Commercial Model
 Eyeforpharma.com 2010 Mar 30
 
http://social.eyeforpharma.com/story/why-pharma-needs-new-commercial-model
HSL17560
 Lam T
 PM orders inquiry into US drug-company kickbacks for doctors
 Saigon GP Daily 2010 Mar 30
 
http://www.saigon-gpdaily.com.vn/Health/2010/3/80663/
HSL17613
 Wokasch M
 Healthcare reform driven marketing challenges to 'stimulating product interest'
 Pharma Reform 2010 Mar 30
 
http://www.pharmareform.com/2010/03/30/healthcare-reform-driven-marketing-challenges-to-stimulating-product-interest/
HSL17618
 Wilson D
 Risks Seen in Cholesterol Drug Use in Healthy People
 The New York Times 2010 Mar 30
 
http://www.nytimes.com/2010/03/31/business/31statins.html
HSL17504
 Silverman E
 A Sanofi Drug, A Web Site & Lack Of Disclosure
 Pharmalot 2010 Mar 29
 
http://www.pharmalot.com/2010/03/a-sanofi-heart-drug-a-web-site-lack-of-disclosure/
HSL17344
 O’Hanlon S
 My year without drug reps
 BMJ 2010 Mar 29;340:c1102
 
http://www.bmj.com/cgi/content/extract/340/mar03_2/c1102
HSL17506
 Mack J
 MicroBlogging About 'Newsworthy' Events: Should Pharma Follow FDA's Lead?
 Pharma Marketing Blog 2010 Mar 29
 
http://pharmamkting.blogspot.com/2010/03/microblogging-about-newsworthy-events.html
HSL17521
 Cegedim Strategic Data (CSD) Releases Global Pharmaceutical Marketing Investment Figures for 12 Months Ending December 2009
 Market Watch 2010 Mar 29
 
http://www.marketwatch.com/story/cegedim-strategic-data-csd-releases-global-pharmaceutical-marketing-investment-figures-for-12-months-ending-december-2009-2010-03-29
HSL17534
 Wokasch M
 Healthcare Reform Impact on Pharmaceutical Marketing
 Pharma Reform 2010 Mar 29
 
http://www.pharmareform.com/2010/03/29/healthcare-reform-impact-on-pharmaceutical-marketing/
HSL17547
 Macrae F
 Pill-popper nation: Prescriptions soar as we pick up more than 16 EACH every year
 The Daily Mail 2010 Mar 29
 
http://www.dailymail.co.uk/news/article-1261436/A-nation-pill-poppers-Prescriptions-soar-pick-16-EACH-year.html
HSL17669
 Russia passes Pharmaceutical Bill
 PM Live 2010 Mar 29
 
http://www.pmlive.com/find_an_article/allarticles/categories/General/2010/march/news/russia_passes_pharmaceutical_bill
HSL17670
 Rowley M
 Building a good defence
 PM Live 2010 Mar 29
 
http://www.pmlive.com/find_an_article/allarticles/categories/General/2010/march/featureds/building_a_good_defence
HSL17752
 O'Hanlon S.
 My year without drug reps.
 BMJ 2010 Mar 29;340:c1102:
 
http://www.bmj.com/cgi/content/full/340/mar29_2/c1102?view=long&pmid=20351076
HSL17487
 W5 Investigates: Pills, Patients and Profits
 CTV W5 2010 Mar 27
 
http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/20100326/w5_pills_100326/20100327
HSL17509
 Cleaver H
 Rösler infuriates pharma industry with plan to cut drugs costs
 The Local 2010 Mar 27
 
http://www.thelocal.de/money/20100327-26165.html
HSL17490
 Wang SS
 Let the Sun Shine In: Payments to Docs from Companies to be Disclosed
 The Wall Street Journal 2010 Mar 26
 
http://blogs.wsj.com/health/2010/03/26/let-the-sun-shine-in-payments-to-docs-from-companies-to-be-disclosed/
HSL17491
 Edwards J
 This Oral-Sex Cancer Scare Brought to You by GlaxoSmithKline
 BNet 2010 Mar 26
 
http://industry.bnet.com/pharma/10007425/this-oral-sex-cancer-scare-is-brought-to-you-by-glaxosmithkline/
HSL17492
 Edwards J
 Did Sanofi Sponsorship Push the Legal Envelope on Its Disappointing New Heart Drug?
 BNet 2010 Mar 26
 
http://industry.bnet.com/pharma/10007414/sanofi-pushes-the-legal-envelope-on-its-disappointing-new-heart-drug/
HSL17499
 Carlat D
 The Physician Sunshine Act: Time for Hired Guns to Scatter
 The Carlat Psychiatry Blog 2010 Mar 26
 
http://carlatpsychiatry.blogspot.com/2010/03/physician-sunshine-act-time-for-hired.html
HSL17594
 Kim K, Seong Park J
 Message framing and the effectiveness of DTC advertising: The moderating role of subjective product knowledge
 Journal of Medical Marketing 2010 Mar 26;10:(2):165–176
 
http://www.palgrave-journals.com/jmm/journal/v10/n2/abs/jmm20104a.html
HSL17505
 Whelan D
 Little Pricey Pill
 Forbes 2010 Mar 25
 
http://www.forbes.com/forbes/2010/0412/opinions-healthcare-nexium-hmo-prescriptions-heads-up.html
HSL17485
 Iskowitz M
 In protecting market research, federal exclusion may not always apply
 Medical Marketing & Media 2010 Mar 25
 
http://www.mmm-online.com/in-protecting-market-research-federal-exclusion-may-not-always-apply/article/166563/?DCMP=EMC-
HSL17486
 Nussbaum A, Tirrell M, Wechsler P
 Health Law Surprise Is Page 1,617 Demanding Which Drugs Work
 Bloomberg News 2010 Mar 25
 
http://www.bloomberg.com/apps/news?pid=20601202&sid=aWaqUjSAjgAg
HSL17488
 US jury's Neurontin ruling to cost Pfizer $141 mln
 Reuters 2010 Mar 25
 
http://www.reuters.com/article/idUSN259778920100325
HSL17500
 Brody H
 More on Strict Measures Proposed in India
 Hooked: Ethics, Medicine and Pharma 2010 Mar 25
 
http://brodyhooked.blogspot.com/2010/03/more-on-strict-measures-proposed-in.html
HSL17617
 Arnold M
 Europe edges US in social media for health info, says study
 Medical Marketing & Media 2010 Mar 25
 
http://www.mmm-online.com/europe-edges-us-in-social-media-for-health-info-says-study/article/166461/
HSL17431
 Insel TR
 Psychiatrists' Relationships With Pharmaceutical Companies: Part of the Problem or Part of the Solution?
 JAMA 2010 Mar 24;303:(12):1192-1193
 
http://jama.ama-assn.org/cgi/content/short/303/12/1192
HSL17434
 Bassler D, Briel M, Montori VM, Lane M, Glasziou P, Zhou Q, Heels-Ansdell D, Walter SD, Guyatt GH
 Stopping Randomized Trials Early for Benefit and Estimation of Treatment Effects
 JAMA 2010 Mar 24;303:(12):1180-1187
 
http://jama.ama-assn.org/cgi/content/abstract/303/12/1180
HSL17435
 DeAngelis CD, Fontanarosa PB
 Ensuring Integrity in Industry-Sponsored Research
 JAMA 2010 Mar 24;303:(12):1196-1198
 
http://jama.ama-assn.org/cgi/content/extract/303/12/1196
HSL17437
 Nissen SE
 Setting the RECORD Straight
 JAMA 2010 Mar 24;303:(12):1194-1195
 
http://jama.ama-assn.org/cgi/content/extract/303/12/1194
HSL17493
 Edwards J
 Medical Journals: Still Too Lazy to ID Pharma-Funded Research
 BNet 2010 Mar 24
 
http://industry.bnet.com/pharma/10007359/in-the-lazy-world-of-medical-journals-pharma-funding-often-goes-unnoticed/
HSL17542
 Consumer watchdog air concerns over Sigma reward program
 International Business Times 2010 Mar 24
 
http://ibtimes.com.au/articles/20100324/consumer-watchdog-air-concerns-over-sigma-reward-program.htm
HSL17543
 Lekakis G
 Watch on chemist reward scheme
 The Herald Sun 2010 Mar 24
 
http://www.heraldsun.com.au/business/watch-on-chemist-reward-scheme/story-e6frfh4f-1225844496833
HSL17578
 Citrome L
 Citability of Original Research and Reviews in Journals and Their Sponsored Supplements
 PLoS One 2010 Mar 24;
 
http://www.plosone.org/article/info:doi/10.1371/journal.pone.0009876
Page 18 of 206 pages ‹ First < 16 17 18 19 20 > Last ›
 








 


